About Andrew Krouse
Andrew Krouse is a founder, president & chief executive officer, director at Navion Neurosciences.
Form D filings also name Andrew Krouse as a chief executive officer and director at Slate Bio.
Andrew Krouse first appears on SEC filings in 2021.
Experience
This experience comes from Andrew Krouse's profile and from SEC filings. For roles taken from filings, the years are when the filings name Andrew Krouse in the role, so the role may have started earlier or lasted longer.
Navion Neurosciences Inc. Current
Founder, President & Chief Executive Officer, director
President and CEO (2026 – Present)
2023 – Present · Charlottesville, VA
Develops medicines for people with genetic epilepsy and chronic nerve pain.
UG
University of Virginia Licensing & Ventures Group
Entrepreneur-in-Residence
2019 – 2026
CP
Cavion, Inc. (Aquired by Jazz Pharmaceuticals)
President and CEO
2014 – 2019
TI
Tau Therapeutics LLC (Acquired by Cavion, Inc)
President and CEO
2006 – 2014
UB
University of Virginia Darden School of Business
Vice President
1994 – 2005
GC
Georgetown University Law Center
Associate Director of Development
1990 – 1994
GS
Goldman Sachs
Analyst
1986 – 1989
Key Colleagues at Startups
The people Andrew Krouse works with at each company, as listed on that company's latest Form D.
Navion Neurosciences Inc. · Form D, Sep 22, 2026
MB
Marianne Bjordal
Director
SR
Suman Rao
Director
Slate Bio, Inc. · Form D/A, May 25, 2023
KW
Kurt Woerpel
Executive officer
RC
Robert Creeden
Director
KS
Kyparissia Sirinakis
Director
BG
Brian Gallagher
Director